Cyteir Therapeutics Inc. (CYT)

AI Score

Unlock

3.02

-0.07 (-2.27%)

At close: Mar 15, 2024, 8:00 PM

Cyteir Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	129.24M	133.63M	137.2M	147.12M	153.89M	166.4M	177.38M	189.72M	199.82M	198.64M	84.19M	10.94M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	259K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	261K	260K	n/a	2.32M	2.48M	2.63M	2.88M	256K	256K	256K	972K	317K
Receivables	n/a	95K	252K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	-17K	-95K	-252K	n/a	n/a	n/a	n/a	-38K	n/a	n/a	n/a	n/a
Other Current Assets	1.4M	183K	1.19M	2.09M	3.46M	3.31M	3.6M	3.35M	4.4M	1.67M	1.19M	1.19M
Total Current Assets	130.64M	133.91M	138.39M	149.21M	157.35M	169.71M	180.99M	193.08M	204.22M	200.31M	85.39M	12.13M
Property-Plant & Equipment	105K	215K	323K	1.7M	1.87M	2.03M	2.1M	2.06M	1.63M	1.49M	1.43M	1.29M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	366K	475K	582K	4.02M	4.35M	4.66M	4.97M	2.31M	1.89M	1.75M	2.4M	1.6M
Total Assets	131.01M	134.39M	138.98M	153.23M	161.7M	174.37M	185.96M	195.39M	206.11M	202.05M	87.79M	13.73M
Account Payables	508K	1.34M	674K	1.13M	1.67M	3.61M	3.51M	1.78M	3.28M	3.51M	2.81M	1.69M
Deferred Revenue	-16K	-57K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	16K	57K	98K	889K	900K	893K	887K	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	5.45M	5.18M	3.19M	3.3M	3.25M	4M	4.76M	5.73M	4.25M	3.93M	1.46M	1.45M
Total Current Liabilities	5.97M	6.58M	3.96M	5.32M	5.82M	8.51M	9.15M	7.51M	7.53M	7.44M	4.26M	3.14M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	9K	22K	39K	1.63M	1.85M	2.08M	2.3M	585K	737K	754K	138.03M	58.63M
Total Long-Term Liabilities	9K	22K	39K	1.63M	1.85M	2.08M	2.3M	585K	737K	754K	138.03M	58.63M
Total Liabilities	5.98M	6.6M	4M	6.95M	7.66M	10.58M	11.46M	8.1M	8.27M	8.2M	142.29M	61.77M
Total Debt	16K	57K	98K	889K	900K	893K	887K	n/a	n/a	n/a	n/a	n/a
Common Stock	35K	35K	35K	35K	35K	35K	35K	35K	35K	34K	2K	2K
Retained Earnings	-162.54M	-159M	-150.6M	-138.11M	-129.32M	-118.28M	-106.16M	-92.05M	-80.24M	-68.53M	-57.24M	-49.93M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	-185.96M	n/a	-206.11M	-202.05M	n/a	n/a
Shareholders Equity	125.03M	127.79M	134.98M	146.29M	154.03M	163.78M	174.5M	187.29M	197.84M	193.85M	-54.5M	-48.03M
Total Investments	n/a	n/a	259K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a